References
- Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JHM, Beasley MB, Chirieac LR, Dacic S, Duhig E, Flieder DB, Geisinger K, Hirsch FR, Ishikawa Y, Kerr KM, Noguchi M, Pelosi G, Powell CA, Tsao MS, Wistuba I; WHO Panel. The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiological Advances Since the 2004 Classification. J Thorac Oncol. 2015; 10(9): 1243-60.
- Silva DL, Pinto P, Costa M, Maia R, Rodrigues C. Pneumothorax as a Presentation of Tuberous Sclerosis Associated Lymphangioleiomyomatosis. Eur J Case Rep Intern Med. 2019; 6(10): 001264.
- Crawford TC, Grimm JC, Magruder JT, Stephens RS, Sciortino CM, Vaught AJ, Althaus J, Shah AS, Kim BS. A curious case of acute respiratory distress syndrome. J Surg Case Rep.; 2015(11) pii: rjv140.
- Pais F, Fayed M, Evans T. Lymphangioleiomyomatosis: an explosive presentation of a rare disease. Oxf Med Case Reports. 2017; 2017(6):omx023.
- Grzegorek I, Lenze D, Chabowski M, Janczak D, Szolkowska M, Langfort R, Szuba A, Dziegiel P. Immunohistochemical evaluation of pulmonary lymphangioleiomyomatosis. Anticancer Res. 2015; 35(6): 3353-60.
- Xu KF, Lo BH. Lymphangioleiomyomatosis: differential diagnosis and optimal management. Ther Clin Risk Manag. 2014; 10: 691-700.
- Hu S, Wu X, Xu W, Tian X, Yang Y, Wang ST, Liu S, Xu X, Xu KF. Long-term efficacy and safety of sirolimus therapy in patients with lymphangioleiomyomatosis. Orphanet J Rare Dis. 2019;14 (1):206
- Johnson SR, Cordier JF, Lazor R, Cottin V, Costabel U, Harari S, Reynaud-Gaubert M, Boehler A, Brauner M, Popper H, Bonetti F, Kingswood C; Review Panel of the ERS LAM Task Force. European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur Respir J. 2010; 35(1):14-26.